Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency

European Journal of Endocrinology

Volumn 154, Issue 6, 2006, Pages 859-864

  Luczay, A ^a   Török, Dora ^a   Ferenczi, A ^a   Majnik, J ^a   Solyom J ^a   Fekete, Gy ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; RENIN; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ALLELE; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUNGARY; INDIVIDUALIZATION; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIZATION; SEX DIFFERENCE; TREATMENT PLANNING; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; STEROID 21-HYDROXYLASE;

EID: 33745712816     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02162     Document Type: Article

References (31)

1. White PC & Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000 21 (3) 245-291.
2. Merke DP & Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005 365 2125-2136.
3. Hughes I. Congenital adrenal hyperplasia: phenotype and genotype. Journal of Pediatric Endocrinology and Metabolism 2002 15 1329-1340.
4. Witchel SF, Bhamidipati DK, Hoffman EP & Cohen JB. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 4081-4088.
5. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI & White PC. Disease expression and molecular genotype in congenital adrenal hyperplasia, due to 21-hydroxylase deficiency. Journal of Clinical Investigation 1992 90 584-595.
6. Alfaidy N, Li W, MacIntosh T, Yang K & Challis J. Late gestation increase in 11 beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. Journal of Clinical Endocrinology and Metabolism 2003 88 5033-5038.
7. Chemaitilly W, Betensky BP, Marshall I, Wei JQ, Wilson RC & New MI. The natural history and genotype-phenotype nonconcordance of HLA identical siblings with the same mutations of the 21-hydroxylase gene. Journal of Pediatric Endocrinology and Metabolism 2005 18 143-153.
8. Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fekete C, Morel Y & Brauner R. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. Journal of Clinical Endocrinology and Metabolism 2003 88 2624-2633.
9. Huizenga NATM, Koper JW, Do Lange P, Pols HA, Stolk RP, Burgr H, Groobee DE, Brinkmann AO, De Jong FH & Lamberts SW. A polymorphism in glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. Journal of Clinical Endocrinology and Metabolism 1998 83 144-151.
10. Lin RC, Wang WY & Morris BJ. High penetrance, overweight, and glucocorticoid receptor variant: case control study. British Medical Journal 1999 319 1337-1338.
11. Dobson MG, Redfern CPF, Unwin N & Weaver JU. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2001 86 2270-2274.
12. Lin RCY, Wang XL, Bronwen D, Caterson ID & Morris BJ. Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obesity Research 2003 11 802-808.
13. Rosmond R. Letter: Glucocorticoid receptor N363S variant in obesity: comes into vanity and goes into darkness. Obesity Research 2003 11 1606-1607.
14. Majnik J, Patocs A, Balogh K, Toth M, Gergics P, Szappanos A, Mondok A, Borgulya G, Panczel P, Prohaszka Z & Racz K. Over representation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 2006 [Epub ahead of print].
15. Wedell A, Thilen A, Ritzen EM, Stengler B & Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. Journal of Clinical Endocrinology and Metabolism 1994 78 1145-1152.
16. Prader A & Gurtner HP. Das Syndrom des Pseudohermaphroditismus masculinus bei kongenitaler Nebennierenrindenhyperplasie ohne Androgenüberproduktion (adrenaler Pseudohermaphroditismus masculinus). Helvetica Pediatrica Acta 1955 10 397-412.
17. Solyom J, Gacs G, Keszei K, Lang K, Orley J, Petheo I & Sagodi L. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization. Acta Endocrinologia (Copenh) 1987 115 413-418.
18. Ferenczi A, Garami M, Kiss E, Pek M, Sasvari-Szekely M, Barta C, Staub M, Solyom J & Fekete G. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1999 84 2369-2372.
19. Majnik J, Patocs A, Balogh K, Toth M & Racz K. A rapid and simple method for detection of Asn363Ser polymorphism of the human glucocorticoid receptor gene. Journal of Steroid Biochemistry and Molecular Biology 2004 92 465-468.
20. Kovacs J, Votava F, Heinze G, Solyom J, Lebl J, Pribilincova Z, Frisch H, Battelino T & Waldhauser F. Middle European Workshop on Paediatric Endocrinology - Congenital Adrenal Hyperplasia Study Group. Lessons from 30 years of clinical dignosis and treatment of congenital adrenal hyperplasia in five middle European countries. Journal of Clinical Endocrinology and Metabolism 2001 86 2958-2964.
21. Wilson RC, Mercado AB, Cheng KC & New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. Journal of Clinical Endocrinology and Metabolism 1995 80 2322-2329.
22. Jaaskelainen J, Levo A, Voutilainen R & Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. Journal of Clinical Endocrinology and Metabolism 1997 82 3293-3297.
23. Krone N, Braun A, Roscher AA, Knorr D & Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. Journal of Clinical Endocrinology and Metabolism 2000 85 1059-1065.
24. Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, Lamberts SW & Koper JW. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. Journal of Clinical Endocrinology and Metabolism 2005 90 5804-5810.
25. de Lange P, Kooper JW, Huizenga NATM, Brinkmann AO, de Jong FH, Karl M, Chrousos GP & Lamberts SW. Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Molecular Endocrinology 1997 11 1156-1164.
26. Speiser PW & White PC. Congenital adrenal hyperplasia. New England Journal of Medicine 2003 349 776-788.
27. Cornean RE, Hindmarsh PC & Brook CG. Obesity in 21-hydroxylase deficient patients. Archives of Disease in Childhood 1998 78 261-263.
28. Rosmond R, Bouchard C & Bjorntorp P. Tsp5091 polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. British Medical Journal 2001 322 652-653.
29. Van Wyk JJ & Ritzen EM. The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2003 88 2993-2998.
30. Merke DP, Keil MF, Jones JV, Fields J, Hill S & Cutler GB, Jr. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2000 85 1114-1120.
31. Quintos JB, Vogiatzi MG, Harbison MD & New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2001 86 1511-1517.